Skip Ribbon Commands
Skip to main content



Primary Diagnosis

Mitral Valve Disease

​​Study Purpose

As an extension of the COAPT RCT trial, COAPT CAS study will be conducted after COAPT enrollment is complete under the same investigational device exemption (IDE(G120024)). The objective of this study is to evaluate the MitraClip® NT System for the treatment of clinically significant functional mitral regurgitation (FMR) in symptomatic heart failure subjects who are treated per standard of care and who have been determined by the site's local heart team as not appropriate for mitral valve surgery.

Principal Investigator: Paul Grayburn, MD

Trial Details

Locations: Baylor Heart and Vascular Hospital

Sponsor: Abbott Vascular

IRB Number: 012-111

Trial Status: Enrolling

Exclusions: Adults only

Change in Care: Participating may change your care

Contact Information:

Brittany Zingler, RN

Necole Kell, RN

Full Protocol Title

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) (COAPT)

Get Detailed Inf​ormation ​On »​​​​​​​​​​​​​​​​​​​